1. Who.int. Hepatitis B, WHO Department of communicable diseases surveillance and response[
http://whqlibdoc.who.int/hq/2002/WHO_CDS_CSR_LYO_2002.2_HEPATITIS_B.pdf
]
2. Wands JR: Prevention of hepatocellular carcinoma. N Engl J Med 2004, 351: 1567-1570. 10.1056/NEJMe048237
3. Lausanne : Clinical Update - Debio 025 in Hepatitis C.2008. [
http://www.debiopharm.com/media/press-releases/35-debio-025/2858-clinical-update-debio-025-in-hepatitis-c-presentation-of-phase-iia-efficacy-results.html
]
4. Behrens SE, Tomei L, DeFrancesco R: Identification and properties of the RNA-dependent RNA polymerase of hepatitis C virus. EMBO J 1996, 15: 12-22.
5. World Health Organization: Department of Measurement and Health Information.2004. [
http://www.who.int/healthinfo/statistics/bodgbddeathdalyestimates.xls
]